|
|
Other links at Articles > Allergy and Clinical Immunology |
| 1. |
Pneumococcal Vaccination in Young Children Lowers Healthcare Utilization
|
|
|
Among children less than 2 years old, rates of hospitalization and ambulatory care visits for treatment of pneumonia have been cut in half since the heptavalent pneumococcal conjugate vaccine (PCV7) was added to the routine childhood immunization schedule in 2000. Reuters Health Information
|
| 2. |
FDA Approvals: ProAir HFA and Nasacort AQ
|
|
|
The FDA has approved expanded indications for an albuterol sulfate inhalation aerosol (ProAir HFA) and triamcinolone acetonide nasal spray (Nasacort AQ). Medscape Medical News
|
| 4. |
Omalizumab Cost-Effective for Severe Persistent Allergic Asthma
|
|
|
The anti-IgE antibody omalizumab is cost-effective for treating patients with severe persistent allergic asthma despite high-dose inhaled corticosteroid (ICS) plus a long-acting beta-2-agonist (LABA), according to a report in the June issue of Allergy. Reuters Health Information
|
| 5. |
The Top Ten Unfounded Health Scares of the Year
|
|
|
Elizabeth M. Whelan, ScD, MS, MPH, President, Founder, American Council on Science and Health, New York, compares notes on the top 10 health-scare myths of 2007.
The Medscape Journal of Medicine
|
|
|